Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Fierce 15 nominations are now open! We're looking for the best and brightest in biotech.
Prevnar
Biotech
Merck compares pneumococcal vaccine to 1983 warhorse
Merck has presented successful clinical results for its investigational pneumococcal vaccine V116, which is up for FDA approval in June of this year.
Kevin Dunleavy
Apr 29, 2024 9:00am
Merck strides onto Pfizer’s turf with pivotal vaccine data
Nov 28, 2023 8:20am
Merck's next-gen pneumococcal vaccine receives breakthrough tag
Apr 14, 2022 9:35am
Affinivax nabs huge $226M funding round
Jan 8, 2021 8:35am